A new study conducted by researchers at USC’s Keck School of Medicine explored a popular artificial sweetener – sucralose. ...

Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.

Key Takeaways More people with type 1 diabetes are severely obese and using GLP-1 drugs for weight lossExperts are concerned ...

A new study, conducted by researchers at the Keck School of Medicine USC, reveals that consuming sucralose activates the ...

A new USC study reveals that sucralose, a popular artificial sweetener, may trick the brain by triggering hunger-related ...

A study by USC reveals that sucralose, a common artificial sweetener, alters brain activity in regions controlling hunger.

The equity financing is at a 10% premium to the market share price1 ZÜRICH, SWITZERLAND / ACCESS Newswire / March 31, 2025 / NLS Pharmaceutics Ltd.(NASDAQ:NLSP) ("NLS" or the "Company"), a Swiss ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

A Medicine study used artificial intelligence to discover a naturally occurring molecule, specifically, a peptide, that ...

An estimated 15 million Americans are currently taking semaglutide weight loss drugs, which are proven to impact alcohol ...

Inhaled insulin has been available for about a decade, offering a rapid-acting alternative to traditional insulin shots.

Glucofreedom, is FDA-approved and fulfills GMP quality as per required healthrequirements, making it top selling product in ...